Protagonist Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

프로타고니스트 테라퓨틱스NASDAQ:PTGX · Nasdaq · Healthcare

$140.63+0.41%

2026-10-05 close · prelim

Protagonist Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $434M. 2024 operating profit was $253M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy